Shamir Optical Industry Reports Fourth Quarter and Year-End 20... (gives us reason to feel confident that w...)

Shamir Optical Industry Reports Fourth Quarter and Year-End 2009 Results

Date:3/11/2010

gives us reason to feel confident that we will achieve similar success in 2010. Our strategy remains intact, which includes continued operational excellence and penetration into new markets."

For the fiscal year ending on December 31, 2010, Shamir currently estimates its 2010 revenues growth in the range of 8%-12%, under the assumption of December 2009 exchange rates.

Conference Call:

Shamir has scheduled a conference call for 10:30 a.m. ET today to discuss fourth quarter and year-end 2009 results. To participate in the call, please dial (888) 562-3356 (U.S. and Canada) or (973) 582-2700 (International). The conference ID for this event is 57774730. For those unable to participate there will be replay available from 1:30 p.m. ET on March 11, 2010, through 11:59 p.m. EDT, March 18, 2010. Please call: (800) 642-1687 (U.S. and Canada) (706) 645-9291 (International). The ID code for the replay is 57774730.

SOURCE Shamir Optical Industries Ltd.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/23/2013)... A medical malpractice case which was filed ... by Lori Mandel, an office manager in her 50’s, ... Ms. Mandel sought the medical expertise of an ... that affected the quality of her life and her ... that her doctor rendered conservative treatment for 2 years, ...

(Date:5/23/2013)... International Science Consortium, Ltd., issued the following statement ... 2013: , Reform of chemical safety legislation will ... , Ensuring the safety and appropriate use ... the EPA,s Toxic Substances Control Act is a ... vision for transforming toxicity testing "from a system ...

(Date:5/23/2013)... in imaging of brain activity developed by Jean ... and his colleagues lead to improved treatment of ... electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) ... generating epileptic seizures, giving neurosurgeons a better understanding ... These results were presented at the 2013 ...

(Date:5/23/2013)... Bronson Gray HealthDay Reporter , , WEDNESDAY, May 22 ... device used to save an infant born with a serious ... marriage of bioengineering and surgery. A report in the ... the situation that sparked the innovation. At first, the ... began to have difficulty breathing and eating when he was ...

(Date:5/23/2013)... According to a new market report "Service Delivery ... Management (SDM); Telecom Application Server; Service Creation Environment; Orchestration ... published by MarketsandMarkets, the SDP Market is expected to ... 9.15% from 2013 to 2018. , Browse:, ... 84 Figures , 189 Pages and an ...

Breaking Medicine News(10 mins):Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2 Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3 Health News:New imaging techniques used to help patients suffering from epilepsy 2 Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2 Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3 Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2 Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3

[0] New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury [0] Chemical Safety Improvement Act of 2013: PETA International Science Consortium [0] New imaging techniques used to help patients suffering from epilepsy [0] Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant [0] Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets

... , ENGLEWOOD, Colo., Aug. 10 Baxa, ... and administration of fluid medications, announces the launch of a ... and medication safety practices. The Culture of Safety Page, ... share experiences, insights and ideas for improving their profession and ...

... Aug. 10 /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin ... leading,developer and distributor of prescription and over the ... supplements, and,medical devices and medical formulations, today announced ... a.m. Eastern Time on Thursday, August 13, 2009, ...

... , SAN FRANCISCO, Aug. 10 ... Mark Gastineau to senior vice president and chief executive of ... Unit (ISGBU). Gastineau joined Blue Shield in 2006 as ... underwriting and compliance areas in developing strategies to increase membership ...

... ... and school administrators will help U.S. schools meet growing needs of students with autism ... ... Society announced the publication of professional competencies for teaching students with autism spectrum disorders ...

... , , NEW YORK, Aug. 10 ... letter of intent to form ZiRx Therapeutics, Ltd., a joint venture that ... cell proteins with drugs that potentially block or stop the spread of ... to broad spectrum antiviral drugs as well as drugs that are less ...

... YORK, Aug. 10 In an unprecedented meeting at the UN, ... and currently an opposition leader and human rights protagonist for Iran, ... violations of human rights by the regime in Iran. , ... Secretary General for his June 22 statement of urgent concern over ...

Cached Medicine News:Health News:Baxa Corporation Launches 'Culture of Safety' Facebook Page 2 Health News:Baxa Corporation Launches 'Culture of Safety' Facebook Page 3 Health News:China Medicine Announces Conference Call to Discuss Second Quarter 2009 Results 2 Health News:Mark Gastineau Named Senior Vice President of Individual, Small Group, and Government Business Unit at Blue Shield of California 2 Health News:New National Professional Competencies for Teachers of Autism Released by Leaders in the Field 2 Health News:New National Professional Competencies for Teachers of Autism Released by Leaders in the Field 3 Health News:Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd. 2 Health News:Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd. 3 Health News:Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General 2

Baxa Corporation Launches 'Culture of Safety' Facebook Page China Medicine Announces Conference Call to Discuss Second Quarter 2009 Results Mark Gastineau Named Senior Vice President of Individual, Small Group, and Government Business Unit at Blue Shield of California New National Professional Competencies for Teachers of Autism Released by Leaders in the Field Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd.Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General

(Date:5/23/2013)... , May 23, 2013 Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...

(Date:5/23/2013)... , May 23, 2013 Spring Bank Pharmaceuticals, ... treatment of viral infections, today announced that it has ... 9200, its investigational, once daily, oral therapy for the ... healthy, HCV-infected patients and is designed to assess both ... 9200 is a first-in-class drug for the treatment of ...

(Date:5/23/2013)... 2013 Direct to implant, or "one ... appropriate option for many women with BRCA (BReast ... breast cancer risk, or with breast cancer. Traditionally, ... a second surgery to insert permanent implants, but ... as mastectomy can be a medically and cosmetically ...

Breaking Medicine Technology:First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4 Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2 Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3

[0] First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection [0] Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients [0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results

... , , , , , , ... MIVI-TRUST Phase III Program With Microplasmin Recruits a Total of Over,640 ... (Euronext Brussels: THR), a biopharmaceutical company,focused on the discovery and development ... that it has completed,the enrolment of the second Phase III trial ...

... , NORCROSS, Ga., Dec. 15 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that it will ... 6, 2010 after the market close. The Company will host ... a.m. (Eastern Time) to discuss the results. , ...

Cached Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2 ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3 ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4

ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010

...

The AGC Revision Knee, extends the AGC Family to include implants for severe primary knees or revision. Provides rotational freedom of +/- 2 and varus/valgus freedom of +/- 1.5....

The Performance Knee System is a wide and easy to use system that offers enough options to cover any indication for primary and revision knee surgery, and all this with extensive intraoperative flexi...

Medicine Products:

Advance Uni-Comparental Knee Components - Uni Metal-backed Tibial Component Oxford Unicomparental Knee AGC Revision knee Performance - Total Knee System